Richard H. Carmona, MD, MPH, FACS, 17th Surgeon General of the United States, is vice chairman of Canyon Ranch, president of the Canyon Ranch Institute and a distinguished professor at the University of Arizona. Born to a poor immigrant family in New York City, Dr. Carmona dropped out of high school and enlisted in the U.S. Army where he received his GED and went on to become a combat-decorated Special Forces Vietnam veteran. He ultimately attended college and medical school and distinguished himself academically to include being the recipient of the UCSF Medical School Gold Cane as the top graduate. Dr. Carmona trained as a surgeon with subspecialty in trauma, critical care and burns. He has also held many jobs over the years, to include, lifeguard, paramedic, registered nurse, police officer, and university professor.
Robert T. Croyle, PhD
Mitch Golant, PhD, is a health psychologist and Senior VP of Research & Training for the Cancer Support Community (CSC). He has been with CSC for over 28 years where he supervised and trained CSC’s professional clinical staff. He has facilitated over 6,000 support groups for people with cancer and trained over 400 professionals nationally and internationally in CSC's Patient Active Support Group model. Dr. Golant is widely recognized as a pioneer in the use of information technology in cancer education and support through the delivery of online support groups. He was central to the launch of the award-winning Cancer Support Community Online in both English and Spanish and Group Loop: Teens. Talk. Cancer. Online. He has presented globally on CSC’s Patient Active programs and evidence-based research. He has previously served on the Board of Directors for the American Psychosocial Oncology Society. He will receive the Los Angeles County Psychological Association’s Distinguished Contribution in Psychology Award in October 2011. He is the contributing editor to the Essentials of Psychosocial Oncology Handbook (2006) and The Psychiatric and Psychological Dimensions of Pediatric Cancer Symptom Management (2008). He is also the co-author of seven books.
Melissa Hudson, MD, is a Member and Director of the Cancer Survivorship Division in the Department of Oncology. For 15 years, Dr. Hudson served as the St. Jude Principal Investigator of the Pediatric Hodgkin’s Group trials. Dr. Hudson became the Director of the After Completion of Therapy (ACT) Clinic in 1993, which now supervises the care of over 5000 long-term childhood cancer survivors treated on St. Jude trials. During her tenure as Director, the ACT Clinic evaluation evolved to include a series of focused educational interventions aiming to increase survivor knowledge and cancer and its associated health risks and motivate the practice of health protective behaviors. Dr. Hudson disseminated the St. Jude model of risk-based survivor care through her activities in the Children’s Oncology Group (COG) as Co-Chair of the COG Long-Term Follow-Up Guidelines for Survivors of Childhood, Adolescent and Young Adult Cancer. She is also the Chair of the Childhood Cancer Survivor Study (CCSS) Education Committee. Dr. Hudson has collaborated with CCSS and COG investigators in a variety of health promotion initiatives targeting childhood cancer survivors and has published widely on her research initiatives.
J. Leonard Lichtenfeld, MD, MACP, is Deputy Chief Medical Officer for the American Cancer Society. He directs the Society’s Cancer Control Science Department and oversees the Society’s cancer control programs in health disparities, global health and the preventive health partnership with the American Heart Association and the American Diabetes Association. Dr. Lichtenfeld is recognized as a valuable resource for his expertise in oncology and medical affairs. A board certified medical oncologist and internist who was a practicing physician for over 19 years, Dr. Lichtenfeld has long been active in medical affairs on a local, state, and national level. He has a long-standing interest in legislative and regulatory issues, quality medical care and the role of health information technology in healthcare delivery. Dr. Lichtenfeld is a graduate of the University of Pennsylvania and Hahnemann Medical College (now Drexel University College of Medicine) in Philadelphia. His postgraduate training was at Temple University Hospital in Philadelphia, Johns Hopkins University School of Medicine and the National Cancer Institute in Baltimore. He is a member of Alpha Omega Alpha, the national honor medical society and he has been designated a Master of the American College of Physicians.
Dr. Diane E. Meier, MD, FACP, is the Director of the Center to Advance Palliative Care (CAPC). Under her leadership the number of palliative care programs in U.S. hospitals has more than tripled in the last 5 years. She is also Director of the Lilian and Benjamin Hertzberg Palliative Care Institute; Professor of Geriatrics and Palliative Medicine; and Catherine Gaisman Professor of Medical Ethics at Mount Sinai School of Medicine in New York City. She is currently Principal Investigator of an NCI-funded five-year multisite study on the outcomes of hospital palliative care services in cancer patients. Dr. Meier served as one of Columbia University’s Health and Aging Policy Fellows in Washington DC during the 2009-2010 academic year. Dr. Meier has published extensively in all major peer-reviewed medical journals. Dr. Meier received her BA from Oberlin College and her MD from Northwestern University Medical School. She completed her residency and fellowship training at Oregon Health Sciences University in Portland. She has been on the faculty of the Department of Geriatrics and Adult Development and Department of Medicine at Mount Sinai since 1983.
Paula Trahan Rieger, RN, MSN, CAE, FAAN, is the Chief Executive Officer of the Oncology Nursing Society, based in Pittsburgh, PA. The ONS is the professional home for over 35,000 nurses with an expertise in oncology nursing. Prior to this position, she served as the Director of International Affairs for the American Society of Clinical Oncology. She was employed at The University of Texas M.D. Anderson Cancer Center in Houston for twenty three years; working primarily with an expertise in the fields of biotherapy and cancer genetics. Ms. Rieger received her MS in nursing degree from The University of Texas Health Science Center in Houston, after receiving her BS in nursing degree from the University of California, Los Angeles. In addition, Ms. Rieger has a BS in Biology and has completed studies as a nurse practitioner at The University of Texas Health Science Center/Houston. She has maintained continuous support of the nursing profession through publications, contributions as a research collaborator, and over 200 presentations at scientific and professional meetings. She has been active as a volunteer at both the local and national levels of the Oncology Nursing Society.
K. Scott Baker, MD, MS, is the director of the Cancer Survivorship Program at Seattle Children’s Hospital, Fred Hutchinson Cancer Research Center (FHCRC) and the Seattle Cancer Care Alliance. Dr. Baker is a member of the Clinical Research Division of the FHCRC, Professor in the Department of Pediatrics at the University of Washington, and is the Medical Director of the Pediatric Blood and Marrow Transplantation Program at Seattle Cancer Care Alliance. Dr. Baker is a nationally recognized expert in the field of hematopoietic cell transplantation (HCT) and cancer survivorship. His research interests are in the acute and long- term effects of HCT and are focused on the study of treatment related acute and long-term complications in survivors after transplant.
Marci K. Campbell, PhD, focuses her research on nutrition and health behavior change for health promotion and cancer prevention and control. Dr. Campbell is a full professor in the Department of Nutrition, Gillings School of Global Public Health and Cancer Prevention and Control Program Leader at UNC Lineberger Comprehensive Cancer Center. She is Co-PI of the UNC-LIVESTRONG Center of Excellence in Survivorship. Her research studies focus on investigating health communication strategies aimed at reducing risk factors for cancer and chronic diseases in minority and under-served communities. The approaches include testing effectiveness and cost-effectiveness of computer-tailored interventions and peer-led models on diet, physical activity, and cancer screening behaviors for health promotion and disease prevention in diverse populations; impact of multi-level interventions including individual, social, organization and environmental approaches to address social and economic determinants of health; and dissemination research using evidence-based interventions for improving public health and disease control on a population-wide level and across the cancer continuum.
Dr. Campbell, an inspiring member of our cancer survivorship community, passed away on December 14, 2011. For more information, please visit marcicampbellremembered.web.unc.edu.
Jackie Casillas, MD, is an Associate Professor of Pediatrics at the David Geffen School of Medicine at the University of California Los Angeles (UCLA) in the Division of Hematology-Oncology. Dr. Casillas holds several leadership roles at UCLA including being the Director of UCLA’s Pediatric Cancer Survivorship Program. She is co-director of the UCLA-LIVESTRONG™ Survivorship Center of Excellence, and co-director of the Patients and Survivors Program at UCLA’s Jonsson Comprehensive Cancer Center’s (JCCC), Division of Cancer Prevention and Control Research. Dr. Casillas is the Principal Investigator on an NIH-funded P20 grant, a feasibility study for a collaborative interaction between a community organization serving Latino childhood cancer survivors and UCLA’s JCCC. She is also the lead investigator for a recently funded administrative supplement to UCLA’s Cancer Center Grant, which is piloting a text messaging survivorship intervention. Her research focus includes understanding the healthcare access patterns of adolescent and young adult childhood cancer survivors.
Patricia A. Ganz, MD, a medical oncologist, received her B.A. magna cum laude from Harvard University and her M.D. from the University of California at Los Angeles (UCLA). She completed her training in internal medicine and hematology/oncology at UCLA Medical Center and has been a member of the UCLA School of Medicine faculty since 1978 and the UCLA School of Public Health since 1992. In 1993 she became the Director of the Division of Cancer Prevention and Control Research at the Jonsson Comprehensive Cancer Center. In 1999 she was awarded an American Cancer Society Clinical Research Professorship for “Enhancing Patient Outcomes across the Cancer Control Continuum,” and in 1999 and 2000 received the Susan G. Komen Foundation Professor of Survivorship Award. Dr. Ganz was elected to the Institute of Medicine in 2007, and in 2010 received the American Cancer Society Medal of Honor. She served on the National Cancer Institute Board of Scientific Advisors from 2002-2007 and on the American Society of Clinical Oncology (ASCO) Board of Directors from 2003-2006. She was a founding member of the National Coalition for Cancer Survivorship (NCCS) in 1986, and has directed the UCLA-LIVESTRONG Survivorship Center of Excellence at the Jonsson Comprehensive Cancer Center since 2006.
Linda A. Jacobs, PhD, RN, received her undergraduate and doctoral degrees from the University of Pennsylvania. Dr. Jacobs is board certified as an oncology and primary care nurse practitioner and has an appointment as a Clinical Associate Professor at the School of Nursing at PENN. Dr. Jacobs is the Director of the Living Well After Cancer Program (2001-present), the LIVESTRONG Survivorship Center of Excellence at the Abramson Cancer Center, and in collaboration with Anna Meadows, MD, a national expert in the late effects of pediatric cancer, developed the Living Well After Cancer Program into a national model for the care of the adult cancer survivor. Dr. Jacobs consults with institutions across the country developing similar programs and has an extensive list of publications, many that focus on cancer survivorship.
Alison Faust Jones, RN, ND, CNS, received her Nursing Doctorate degree from the University of Colorado Health Sciences Center in 1998. She is currently serving as a consultant for the Cancer Survivorship Program at the University of Colorado Cancer Center as part of the LIVESTRONG™ Survivorship Center of Excellence Network. Her work has focused on developing survivorship clinics for both adult survivors of pediatric cancers and adult-onset cancers with an emphasis on transitioning patients from the oncology setting to primary care after treatment is complete. She also serves as a consultant to the Psychosocial Program at the University of Colorado Cancer Center.
Mary S. McCabe, RN, MA, is Director of the Cancer Survivorship Program at Memorial Sloan-Kettering Cancer Center. She is a faculty member in the Division of Medical Ethics at the Cornell Weill Medical College. A graduate of Trinity College, Emory University and Catholic University, she held several positions at the National Cancer Institute before joining Memorial Sloan-Kettering Cancer Center. Ms. McCabe has served as a member of many committees, including Co-Chair of the Clinical Research Networks Working Group at the National Institute of Health, Chair of the Clinical Trials Integration Committee at the National Cancer Institute, the Scientific Advisory Board, Lance Armstrong Foundation, and a faculty member of the NCI Progress Review Group - Adolescents and Young Adults with Cancer. She is a member of the Oncology Nursing Society, American Society of Clinical Oncology, American Nurses Association, Women in Cancer Research, and American Society for Bioethics and Humanities. Ms. McCabe has published many peer-reviewed articles, serves on the editorial boards for Seminars in Oncology Nursing, Oncology, and the ASCO Post. She has received numerous awards, including the American Cancer Society Merit Award, Oncology Nursing Society Leadership Award, NIH Outstanding Performance Award, NIH Director’s Award and the Outstanding Alumnae Award, Emory University.
Ken Miller, MD, joined the Dana-Farber Cancer Institute as the co-director of the Perini Cancer Survivorship Center and the director of the Lance Armstrong Foundation Adult Survivorship Program in 2008. After undergraduate studies and medical school training at Tufts University in Boston, Miller completed an internal medicine residency at Yale University. He then trained in medical oncology at Johns Hopkins University and in hematology at the National Institutes of Health. Miller developed an oncology group practice in Maryland before returning to academics to become the founding director of the Connecticut Challenge Cancer Survivorship Program at the Yale Cancer Center. Additionally, he is the editor and author of several books on survivorship.
Betsy Risendal, PhD, currently serves as Co-Director for Lance Armstrong Center of Excellence in Cancer Survivorship at the University of Colorado Cancer Center. Dr. Risendal received her PhD in Epidemiology t the University of Arizona and has a tenure track appointment in the Colorado School of Public Health, Department of Community and Behavioral Health. She is Principal Investigator on an ACS-funded Research Scholar grant to study quality of life, fatigue, and follow-up care patterns in a nation-wide cohort of long-term colon cancer survivors. Her primary research interests include health promotion after cancer, and the interface of public health and cancer survivorship. Dr. Risendal also serves on national and state projects related to patient navigation, including both training and research.
Don Rosenstein, MD, is the director of the UNC Comprehensive Cancer Support Program, with joint appointments in the departments of psychiatry and medicine. He is also the President Elect of the Academy of Psychosomatic Medicine. Rosenstein came to the university from the NIH, where he was clinical director of the National Institute of Mental Health (NIMH) and chief of the Psychiatry Consultation-Liaison Service. He also served as vice chair of the NIH Medical Executive Committee. For many years, Rosenstein chaired both the Clinical Center Ethics Committee and the NIMH Institutional Review Board. In 2008, he received the NIH Director’s Award and also the NIMH Director’s Career Award for Significant Scientific Achievement.
Karen L. Syrjala, PhD is a Member and Director of the Biobehavioral Sciences Department, and Co-Director of the Survivorship Program at the Fred Hutchinson Cancer Research Center. Dr. Syrjala also is a Professor in the Department of Psychiatry and Behavioral Sciences at the University of Washington School of Medicine. She provides clinical services to oncology patients at the Seattle Cancer Care Alliance. Dr. Syrjala has served on many journal editorial boards, including Pain and the Journal of Cancer Survivorship, and numerous national cancer guideline panels, particularly in pain and symptom management, and related to hematopoietic cell transplantation. She has led multi-site, randomized, controlled trials examining behavioral strategies to enhance health outcomes in cancer survivors. Her current research is targeting the behavioral, biological and genomic bases of musculoskeletal complications in survivors. She also is testing internet and mobile methods for meeting surveillance, health promotion and symptom needs of survivors.
Marcia Grant RN, DNSc, FAAN is the Director of Nursing Research & Education, and Professor in the Department of Population Sciences at the City of Hope Comprehensive Cancer Center. She has been a senior researcher for more than 25 years. Her primary program of research focuses on symptom management and quality of life in cancer patients. Dr. Grant is Principal Investigator on several grants including a NCI-funded initiative to improve end of life education in cancer centers. The Survivorship Education for Quality Cancer Care was a comprehensive interdisciplinary project that targeted 204 multidisciplinary teams and included teams from 44 states. She has recently completed an NCI-funded project on A Standardized Nursing Intervention Protocol for Hematologic Cell Transplant Patients. Dr. Grant serves on several national committees and is on the editorial boards for CA: A Journal for Clinicians and Seminars in Oncology Nursing. She has over 200 peer-reviewed publications, and is a fellow in the American Academy of Nursing, and an Oncology Nursing Society Distinguished Researcher. Dr. Grant’s educational leadership is demonstrated in her receipt of the 2003 Oncology Nursing Society Mary Nowotny Excellence in Cancer Nursing Education Award. She received the Oncology Nursing Society Distinguished Award for Lifetime Achievement in 2009, and was honored in the Scientific Research Portrait Gallery at City of Hope in 2010. She has served on numerous NIH-funded research, education and evaluation projects.
Mary M. Gullatte, PhD, RN, has over 33 years of oncology nursing experience. Dr. Gullatte’s clinical nursing background spans the specialties of Hematology/Oncology and Blood and marrow stem cell transplantation. She completed her undergraduate nursing studies at the University of Southern Mississippi, earned a Masters of Nursing Degree from Emory University School of Nursing, in the specialty of Adult Health with a clinical specialty in oncology. Dr. Gullatte completed a Post Masters Adult Nurse Practitioner program at Emory. As a Nurse Practitioner, she focuses on Primary care of the adult population. She holds an Adjunct Faculty position at the Nell Hodgson Woodruff School of Nursing at Emory University. Dr. Gullatte is a May 2008 graduate of the University of Utah, College of Nursing with a PhD in cancer nursing research. Her present position is Associate Chief Nursing Officer, at Emory University Hospital Midtown, Atlanta, Georgia. Dr. Gullatte has presented numerous national and international oncology related topics. She has had the opportunity to contribute to the body of published professional literature through articles and book chapters. Dr. Gullatte was inducted as a Fellow into the American Academy of Nursing in November 2010. She was elected President-elect of the National Oncology Nursing Society in May 2011. Additionally, Dr. Gullatte is an honorably discharged US Air Force, Vietnam era veteran.
Alton Hart, Jr., MD, MPH, is an Associate Professor of Medicine and has joint appointments in the Department of Internal Medicine and the Massey Cancer Center, Virginia Commonwealth University (VCU). Dr. Hart is the Director of Massey Cancer Center’s Adult Cancer Survivorship Clinic and the Associate Scientific Director of VCU’s Center on Health Disparities. His research interests include cancer control and prevention, cancer survivorship, health disparities and community-based research. Dr. Hart is the recipient of a 5-year mentored career development grant from the American Cancer Society to develop an interactive electronic decision aid for prostate cancer screening in partnership with African-American barbershops. Dr. Hart also received funding from the National Cancer Institute’s Cancer Information Service to reduce smoking among African-American men through barbershops. More recently, he received an RO3 from the National Cancer Institute to explore cigarette dependence among African-America men also in partnership with barbershops.
Margaret L. Kripke, PhD, is Professor of Immunology and Vivian Smith Chair Emerita at The University of Texas M.D. Anderson Cancer Center. She served as Executive Vice President of M.D. Anderson until 2007. Dr. Kripke's research interests concern the immunology of the skin and skin cancer, how skin immune function is modified by exposure to ultraviolet light, and how the immune system influences the development of skin cancers. She received numerous awards for her research contributions, including the Lila Gruber Award for Cancer Research from the American Academy of Dermatology, the Research and Lifetime Achievement Awards from the American Society for Photobiology, the Lifetime Achievement Award from the American Skin Association, and the Finsen Medal for Photomedicine from the International Union for Photobiology. Dr. Kripke is a Fellow of the American Association for the Advancement of Science and a member of the President’s Cancer Panel.
Guadalupe Palos, RN, LMSW, DrPH, is the Clinical Research Manager in the Office of Survivorship in the Division of Medical Affairs at The University of Texas M D Anderson Cancer Center. In addition to being a nurse scientist in symptom management, Dr. Palos is licensed in Texas as a masters-prepared social worker and registered nurse. Dr. Palos received her nursing degree at San Jacinto Junior College; a BS in Psychology and a MSW at the University of Houston. She received her DrPH from The University of Texas School of Public Health. As the Principal Investigator of a 5-year NCI-funded research award titled “Effects of Cancer Symptom on Minority Caregiver,” Dr. Palos is examining the effects of underserved cancer patients’ symptoms on the physical and psychological health of minority and non-minority caregivers. Dr. Palos was selected as a Fellow for the NCI’s Cancer, Culture and Literacy Institute, Moffitt Cancer Center. As part of her post-graduate work, she participated in the Integrating Cost Effectiveness Analysis in Research, a collaborative educational course between John Hopkins University, the National Institute for Nursing Research, and the National Institute of Health Agency for Healthcare Research and Quality. She also completed a palliative care fellowship at the Duke Institute for Care at the End-of-Life at Duke University.
Angela Patterson is Vice President and Chief Operating Officer of the Georgia Cancer Coalition, responsible for survivorship, patient navigation, and faith-based initiatives, as well as day-to-day operations. Ms. Patterson is on the Steering Team for Georgia’s Comprehensive Cancer Control Plan, the Georgia Pain Initiative, Cancer Patient Navigators of Georgia, and the LIVESTRONG Survivorship Centers of Excellence Network. After earning a BA in Computer Science at the University of Georgia, she worked in information technology. She started at BellSouth as a programmer and over her 17-year career there, ultimately became Director of the BellSouth Technology Group. In 2001, she was diagnosed with breast cancer. Her cancer journey and post-treatment volunteer work ultimately inspired a career transformation in which she could work professionally to impact cancer control in Georgia.
Sarah R. Arvey, PhD joined the LIVESTRONG Research and Evaluation team in February 2011. Her background is in medical anthropology and she conducts research on Latinos’ healthseeking practices in Cuba, Ecuador, Mexico and the U.S. At LIVESTRONG, Dr. Arvey manages the LIVESTRONG Survivorship Center of Excellence Network, and plays a role in the LIVESTRONG Promotora Training Program and the Fertile Hope program. Before joining LIVESTRONG, Dr. Arvey was a Postdoctoral Fellow in the National Cancer Institute Cancer Education and Career Development Program at the University of Texas, School of Public Health-Health Science Center at Houston. There, her research focused on designing, implementing, and evaluating health programs in which promotores de salud (community health workers for Spanish speakers) delivered cancer screening interventions to medically underserved Latinos. She received her doctoral degree in anthropology and history from the University of Michigan in 2007. Dr. Arvey’s publications are printed in professional journals including Ethnicity & Health, Health Education & Behavior, Hispanic Health International, and the Hispanic American Historical Review.
Ruth Rechis is the Director of Evaluation and Research at LIVESTRONG. During her more than six-years at LIVESTRONG, she has worked to establish the office of Evaluation and Research and helped to design, implement, and evaluate numerous programs and resources for people affected by cancer. In her current role, Dr. Rechis and her team conduct intramural research, oversee extramural research projects, develop and implement strategic yearly evaluation plans, and provide oversight to the LIVESTRONG Survivorship Center of Excellence Network. She is also the principal investigator on the LIVESTRONG Survey for People Affected By Cancer, a comprehensive survey assessing the experience of cancer survivors after treatment ends. As a cancer survivor, she has a personal connection to the mission of LIVESTRONG. Dr. Rechis earned her doctorate in Educational Psychology from the University of Texas at Austin and has published work in journals such as the Journal of Cancer Education and the Journal of Oncology Practice as well as in LIVESTRONG Reports.